A. Cavazza Et Al. , "Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi," Molecular Therapy Nucleic Acids , vol.34, 2023
Cavazza, A. Et Al. 2023. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi. Molecular Therapy Nucleic Acids , vol.34 .
Cavazza, A., Hendel, A., Bak, R. O., Rio, P., Güell, M., Lainšček, D., ... Arechavala-Gomeza, V.(2023). Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi. Molecular Therapy Nucleic Acids , vol.34.
Cavazza, Alessia Et Al. "Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi," Molecular Therapy Nucleic Acids , vol.34, 2023
Cavazza, Alessia Et Al. "Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi." Molecular Therapy Nucleic Acids , vol.34, 2023
Cavazza, A. Et Al. (2023) . "Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi." Molecular Therapy Nucleic Acids , vol.34.
@article{article, author={Alessia Cavazza Et Al. }, title={Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi}, journal={Molecular Therapy Nucleic Acids}, year=2023}